- |||||||||| elcubragistat (Lu AG06466) / Lundbeck
Trial initiation date: Central Pain Study for ABX-1431 (clinicaltrials.gov) - Aug 3, 2017 P1, N=32, Recruiting, Active, not recruiting --> Completed | N=200 --> 241 Initiation date: May 2017 --> Aug 2017
- |||||||||| cyclophosphamide / Generic mfg.
Trial initiation date, Trial termination, Trial primary completion date: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome (clinicaltrials.gov) - Aug 1, 2017 P, N=1, Terminated, Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> May 2017 Initiation date: Aug 2016 --> Apr 2016 | Not yet recruiting --> Terminated | Trial primary completion date: Aug 2021 --> Jul 2016; PI left the institution
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Evaluation of Coagulation in Multiple Sclerosis (clinicaltrials.gov) - Jul 28, 2017
P=N/A, N=69, Completed, Phase classification: P3 --> P=N/A Recruiting --> Completed | N=100 --> 69 | Trial primary completion date: Dec 2016 --> May 2016
- |||||||||| petesicatib (RG7625) / Roche
Trial completion, Enrollment change, Trial primary completion date: A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome (clinicaltrials.gov) - Jul 28, 2017 P2a, N=75, Completed, Recruiting --> Completed | N=100 --> 69 | Trial primary completion date: Dec 2016 --> May 2016 Active, not recruiting --> Completed | N=62 --> 75 | Trial primary completion date: Dec 2017 --> Jun 2017
- |||||||||| Trial primary completion date: MESEMS: MEsenchymal StEm Cells for Multiple Sclerosis (clinicaltrials.gov) - Jul 25, 2017
P1/2, N=12, Recruiting, Recruiting --> Active, not recruiting | N=50 --> 82 | Trial primary completion date: Dec 2015 --> Dec 2017 Trial primary completion date: May 2017 --> May 2018
- |||||||||| Humalog pen (insulin lispro) / Eli Lilly
Trial primary completion date: Environmental Effects Type 1 Diabetes Mellitus (clinicaltrials.gov) - Jul 24, 2017 P=N/A, N=10, Recruiting, Trial primary completion date: Jul 2017 --> Dec 2017 Trial primary completion date: Jun 2017 --> Dec 2017
- |||||||||| losartan potassium / Generic mfg.
Enrollment closed, Trial primary completion date: Efficacy and Safety of Losartan in Children With Ig A Nephropathy (clinicaltrials.gov) - Jul 17, 2017 P3, N=37, Active, not recruiting, Initiation date: May 2017 --> Aug 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| Trial primary completion date: Accu-Chek (clinicaltrials.gov) - Jul 13, 2017
P=N/A, N=200, Completed, Completed --> Terminated; Screening discontinued early due to slow patient enrollment Trial primary completion date: Aug 2016 --> Jan 2017
- |||||||||| Trial completion: Telemedicine Program in Type 1 Diabetes and CSII (clinicaltrials.gov) - Jul 13, 2017
P=N/A, N=51, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Mar 2018 Active, not recruiting --> Completed
|